Abhijith has been writing for the Web since 2011 and has contributed to sites like Beebom and TechWiser. He is curious about making the best of tech accessible to everyone. He started writing as a ...
The US Supreme Court ruled yesterday, June 4, that pharmaceutical company Hikma’s generic cardiovascular drug does not infringe global biopharmaceutical company Amarin’s patents covering its drug ...
WASHINGTON, June 4 (Reuters) - Drugmaker Hikma's (HIK.L), opens new tab generic version of Amarin Pharma's (AMRN.O), opens new tab cardiovascular medication Vascepa did not infringe Amarin's patents, ...
The Java Community Process formally launches development of Java SE 28, with Project Valhalla once again positioned as the release's most closely watched feature.
Elizabeth Doran, a retired Canadian woman, says she has had to pick up extra teaching shifts to afford her semaglutide medication Elizabeth Doran has been taking GLP-1 medications for nearly a year ...
US Supreme Court Backs Generic Drugmaker in 'Skinny Label' Patent Case By Blake Brittain WASHINGTON, June 4 (Reuters) - Drugmaker Hikma's generic version of Amarin Pharma's cardiovascular medication ...
Earlier this year, Canada became the first major market in the world where generic forms of semaglutide became legal. The competition was on: Manufacturers raced to secure Health Canada approval so ...
Section 1. Purpose. The United States continues to lead the world in Artificial Intelligence (AI) because of the enormous talent and innovation of our AI industry, and because we refuse to stifle this ...
Water exhibits a variety of anomalous behaviours. To date, many computer simulations and experimental studies have shown compelling evidence for the existence of a liquid–liquid phase transition ...
(SOA) — What began as warnings from a handful of scientists, whistleblowers and patients has now become the subject of ongoing congressional scrutiny. In the fifth major hearing in the past year, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results